Friedlaender, A.;                     Addeo, A.;                     Russo, A.;                     Gregorc, V.;                     Cortinovis, D.;                     Rolfo, C.D.    
        Targeted Therapies in Early Stage NSCLC: Hype or Hope? Int. J. Mol. Sci. 2020, 21, 6329.
    https://doi.org/10.3390/ijms21176329
    AMA Style
    
                                Friedlaender A,                                 Addeo A,                                 Russo A,                                 Gregorc V,                                 Cortinovis D,                                 Rolfo CD.        
                Targeted Therapies in Early Stage NSCLC: Hype or Hope? International Journal of Molecular Sciences. 2020; 21(17):6329.
        https://doi.org/10.3390/ijms21176329
    
    Chicago/Turabian Style
    
                                Friedlaender, Alex,                                 Alfredo Addeo,                                 Alessandro Russo,                                 Vanesa Gregorc,                                 Diego Cortinovis,                                 and Christian D. Rolfo.        
                2020. "Targeted Therapies in Early Stage NSCLC: Hype or Hope?" International Journal of Molecular Sciences 21, no. 17: 6329.
        https://doi.org/10.3390/ijms21176329
    
    APA Style
    
                                Friedlaender, A.,                                 Addeo, A.,                                 Russo, A.,                                 Gregorc, V.,                                 Cortinovis, D.,                                 & Rolfo, C. D.        
        
        (2020). Targeted Therapies in Early Stage NSCLC: Hype or Hope? International Journal of Molecular Sciences, 21(17), 6329.
        https://doi.org/10.3390/ijms21176329